TXNIP and non-small cell lung carcinoma: Knockdown of TXNIP reversed the inhibition of NSCLC cell proliferation, migration and invasion by circ6834 overexpression (Fig. 6G-I and Supplementary Fig. 9D-F), while TXNIP overexpression reversed the promotion of these malignant progressions by miR-873-5p mimics (Fig. 6J-L and Supplementary Fig. 9G-I).